Investment Rating - The investment rating for BYD is "Buy-A" with a 6-month target price of 454.25 CNY per share [5]. Core Views - BYD's performance in 2024 is expected to be strong, with revenue and profit growth driven by new model launches and favorable domestic demand [2][4]. - The company is anticipated to maintain stable unit profitability, with a slight decline in net profit per vehicle due to increased after-sales costs [3]. - Continued investment in R&D is expected to enhance product competitiveness and support the launch of new high-end models [4]. Financial Performance Summary - In Q4 2024, BYD achieved revenue of 274.85 billion CNY, a year-on-year increase of 53% and a quarter-on-quarter increase of 37%. The net profit attributable to shareholders was 15 billion CNY, up 73% year-on-year and 29% quarter-on-quarter [2]. - For the full year 2024, BYD reported total revenue of 777.1 billion CNY, a 29% increase year-on-year, and a net profit of 40.3 billion CNY, a 34% increase year-on-year [2]. - The company sold 1.51 million passenger vehicles in Q4 2024, representing a 61% year-on-year and 34% quarter-on-quarter increase [2]. Cost and Profitability Summary - The gross margin for the automotive business in Q4 2024 was 25.4%, with a slight year-on-year increase of 0.4 percentage points [3]. - The average selling price (ASP) per vehicle was 145,100 CNY, showing a year-on-year decrease of 600 CNY but a quarter-on-quarter increase of 600 CNY [2]. - R&D expenses for 2024 were 54.2 billion CNY, a 36% increase year-on-year, reflecting the company's commitment to new model development and smart driving technology [4]. Cash Flow and Financial Health - As of Q4 2024, BYD had cash and cash equivalents of 102.3 billion CNY, significantly up from 65.8 billion CNY at the end of Q3 2024 [4]. - The net cash flow from operating activities was 77.2 billion CNY, a 7% year-on-year increase and an 84% quarter-on-quarter increase [4]. Future Outlook - BYD is expected to continue its growth trajectory with a focus on high-end models and international expansion, leveraging its scale and cost advantages [4]. - The projected net profits for 2025, 2026, and 2027 are 55.21 billion CNY, 64.39 billion CNY, and 81.24 billion CNY, respectively, indicating a strong growth outlook [9].

Investment Rating - The investment rating for the company is "Buy-A" with a target price of 35.16 CNY for the next six months [4]. Core Views - The company reported a revenue of 27.95 billion CNY for 2024, representing a year-over-year increase of 13.8%, and a net profit of 3.10 billion CNY, up 6.1% YoY. In Q4 alone, the revenue reached 7.38 billion CNY, marking a significant 32.3% increase YoY, with a net profit of 800 million CNY, up 4.7% YoY [1][2]. - The growth in revenue is attributed to the "old-for-new" policy stimulating demand in the domestic air conditioning and new energy vehicle markets, leading to rapid growth in the company's cooling and automotive parts businesses [1][2]. - The company is a leader in the global refrigeration control components and new energy vehicle thermal management systems, with expectations for rapid revenue growth in strategic emerging businesses such as robotics and energy storage [3]. Financial Performance Summary - The company achieved a revenue of 27.95 billion CNY in 2024, with a projected revenue of 31.77 billion CNY in 2025, 36.39 billion CNY in 2026, and 43.00 billion CNY in 2027 [3][12]. - The net profit for 2024 was 3.10 billion CNY, with forecasts of 3.75 billion CNY in 2025, 4.47 billion CNY in 2026, and 5.51 billion CNY in 2027 [3][12]. - The earnings per share (EPS) are projected to be 1.00 CNY in 2025, 1.20 CNY in 2026, and 1.48 CNY in 2027, with a price-to-earnings (PE) ratio of 35x for 2025 [3][12]. Business Segment Performance - The cooling parts segment saw a revenue increase of approximately 28% in Q4, driven by the "old-for-new" policy and increased demand from emerging markets [1]. - The automotive parts segment experienced a remarkable growth of about 38% in Q4, supported by purchase subsidies and the rapid expansion of the domestic market [2]. - The company is recognized as a leading player in the thermal management of new energy vehicles, with ongoing research and development aimed at enhancing customer value [2].

Investment Rating - The investment rating for the company is "Buy-A" with a target price of HKD 16.59, maintaining the rating [5]. Core Insights - The company reported a revenue of CNY 11.799 billion for 2024, a year-on-year increase of 5.32%, while the net profit attributable to shareholders was CNY 1.303 billion, a decrease of 20.80% [1]. - The company is focusing on expanding its HNB (Heated Not Burned) product line as a second growth curve, with positive trial results for the new product glo Hilo [4][10]. - The company has increased its R&D investment to CNY 1.572 billion in 2024, a year-on-year growth of 41.30%, indicating a commitment to diversifying into nebulization technology and medical applications [4]. Revenue Performance - In 2024, the company's self-owned brand revenue grew by 34.00% to CNY 2.475 billion, accounting for 21.00% of total revenue [2]. - The revenue from enterprise clients was CNY 9.324 billion, a slight decrease of 0.30%, but showed a recovery trend with a 9.70% increase in H2 2024 [3]. - The company achieved revenue of CNY 6.762 billion in H2 2024, reflecting an 11.22% year-on-year increase [1]. Market Performance - The company experienced a strong recovery in the European and American markets, with revenues of CNY 4.24 billion and CNY 20.24 billion respectively, representing year-on-year growth of 14.00% and 37.20% [2]. - In H2 2024, the revenue from the U.S. and European markets was CNY 2.27 billion and CNY 10.95 billion, with growth rates of 8.83% and 11.61% respectively [2]. Profitability Analysis - The gross profit margin for 2024 was 37.39%, a decrease of 1.36 percentage points year-on-year, primarily due to changes in product mix [9]. - The adjusted net profit margin for 2024 was 11.04%, down 3.69 percentage points year-on-year, with H2 2024 adjusted net profit margin at 9.17%, a decline of 6.18 percentage points [9]. Future Projections - Revenue projections for 2025-2027 are CNY 12.823 billion, CNY 14.475 billion, and CNY 16.878 billion, with year-on-year growth rates of 8.68%, 12.88%, and 16.60% respectively [10]. - Net profit projections for the same period are CNY 1.476 billion, CNY 1.809 billion, and CNY 2.242 billion, with growth rates of 13.31%, 22.49%, and 23.94% respectively [10].

Investment Rating - The report maintains a "Buy-A" investment rating for the company [3][6]. Core Insights - The company reported a total revenue of 919 million yuan for 2024, a year-on-year decrease of 4.6%. However, platform technology service revenue surged by 103.6% to 347 million yuan, partially offsetting the impact of Wuxi Guojin's exit from the financial statements. The net profit attributable to shareholders reached 380 million yuan, reflecting a year-on-year increase of 41.7% [2]. - The company has seen a doubling of its platform technology service revenue, with a total of 163 funding partners linked to the platform, an increase of 24% year-on-year, and total funding partner amounts exceeding 36.6 billion yuan, up 58% year-on-year. The cumulative customer base surpassed 18,100, with over 96% being small and micro-enterprises and a retention rate exceeding 80% [2]. - The digital financial solutions revenue decreased by 28% to 522 million yuan, primarily due to Wuxi Guojin's exit in February 2024. The company is focusing on a light asset operation strategy, which is expected to optimize its business structure and enhance platform service revenue and profitability in the long term [3]. - The company is actively embracing the AI era, with cumulative R&D investment exceeding 250 million yuan and nearly 30% of its workforce dedicated to R&D. This is expected to further promote the company's platform development and industrial collaboration [3]. Financial Summary - The company forecasts earnings per share (EPS) of 0.42 yuan, 0.49 yuan, and 0.58 yuan for 2025, 2026, and 2027 respectively. A price-to-earnings (P/E) ratio of 30x for 2025 is applied, leading to a target price of 13.56 HKD over the next six months [3][9]. - The total revenue is projected to recover to 644 million yuan in 2025, with net profit expected to reach 417 million yuan [9].

Investment Rating - The investment rating for the company is "Buy-A" with a target price of HKD 18.84 per share, corresponding to a PE valuation of 20x for 2025 [5][4]. Core Views - The company reported a revenue of CNY 28.24 billion for 2024, a year-on-year decrease of 18.8%, and a net profit of CNY 1.27 billion, down 51.8% year-on-year. The second half of 2024 saw a revenue of CNY 13.82 billion, down 22.0%, and a net profit of CNY 240 million, down 83.6% year-on-year. The decline is attributed to an accelerated inventory clearance strategy [1][2]. - Looking ahead to 2025, the company is expected to benefit from product structure optimization and market share growth due to the effects of trade-in subsidies and new national standards [2][3]. Summary by Sections Financial Performance - In 2024, the company accelerated inventory clearance, leading to a decline in sales volume to 6.64 million units in the second half, a decrease of 20.1% year-on-year, with an average selling price of CNY 2,082, down 2.3% year-on-year [2]. - The net profit margin for the second half of 2024 was 1.7%, down 6.5 percentage points year-on-year, with a gross margin decrease of 4.7 percentage points due to lower selling prices [3]. Market Outlook - The company is focusing on optimizing its supply chain and expanding into overseas markets, with investments in core components like batteries and controllers. It plans to launch its first mass-produced sodium battery electric bicycle in January 2025 [3]. - The company is expanding its production scale in Southeast Asia and deepening its retail network, with factories in Indonesia and Vietnam and flagship stores in Thailand and Indonesia [3]. Earnings Forecast - The company is projected to achieve revenues of CNY 37.56 billion, CNY 40.91 billion, and CNY 46.37 billion for 2025, 2026, and 2027 respectively, with net profits of CNY 2.70 billion, CNY 2.93 billion, and CNY 3.38 billion for the same years [8][9]. - The expected earnings per share (EPS) for 2025, 2026, and 2027 are CNY 0.87, CNY 0.94, and CNY 1.08 respectively [8].

2025 年 03 月 26 日 招商银行(600036.SH) 盈利增长改善、资产质量稳健—招商银行 2024 年报点评 事件：招商银行公布 2024 年年报，2024 年营收同比增长-0.48% （2024 年前三季度增速为-2.91%），拨备前利润同比增长 0.63% （2024 年前三季度增速为-2.66%），归母净利润同比增长 1.22% （2024 年前三季度增速为-0.62%），营收降幅逐季收窄，全年利 润实现正增长，基本面表现稳健，我们点评如下： 招商银行 2024 年四季度归母净利润同比增长 7.64%，其中规模 扩张、非息收入增长、成本压降是主要驱动因素，净息差同比收 窄、计提信用减值同比增加对盈利增长略有拖累。 规模扩张明显提速。去年四季度，招商银行生息资产（日均余 额口径）同比增长 8.76%，较 2024Q3 增速提升 2.23 个百分点， 2024Q4 单季新增生息资产规模（日均余额口径）为 4149 亿元， 仅次于 2023Q1 的资产投放水平，主要是因为大幅增加债券资产、 同业资产配置力度，预计与去年四季度降息、降准后流动性充裕 驱动利率下行，以及政府债券供给增加有关；与此同时 ...

科技相关指数筛选方法：（1）取市场中所有指数产品；（2）计算其最 新成分股在 TMT 板块的持仓占比；（3）将在 TMT 板块持仓占比不 低于 80%的指数定义为科技相关指数。目前共有 185 只指数基金跟 踪科技指数，基金规模合计达 2007.68 亿元。 主动科技主题基金筛选与风格画像 2025 年 03 月 26 日 主题基金面面观之三—科技主题基金盘点与风格画像 本报告是主题基金面面观系列第三篇，在报告中我们着重对当 前市场中的科技指数以及科技主题基金进行盘点，对其市值风 格、集中度、行业配置等特征进行了全面的剖析以及画像。此外， 我们还筛选了半导体以及 AI 主题基金，并对其风格进行画像。 主要科技指数盘点与风格画像 在本报告中，我们构建了科技股票池，更加全面地筛选主动科技主题 基金。具体做法为：（1）取科技指数的所有成分股，将其与中信一级 行业属于 TMT 板块的个股取并集，记为科技股票池；（2）计算主动 权益基金近 4 期所有持股在科技股票池中持仓占比的均值以及最小 值；（3）将在科技股票池中持仓占比的均值大于 60%且最小值大于 40%的主动权益基金定义为主动科技主题基金。目前全市场共有 37 ...

2025 年 03 月 26 日 江中药业(600750.SH) 24 年业绩稳健，OTC 收入延续增长 事件：公司发布 2024 年年报。 2024 年，公司实现营业收入 44.35 亿元，同比下降 2.59%（公司于 2024 年 12 月取得与本公司受同一企业控制的江中饮片 51%的股权， 此处为追溯调整后的数据，下同）；归母净利润 7.88 亿元，同比增长 9.67%；扣非归母净利润 7.49 亿元，同比增长 6.43%。Q4 单季度，公 司实现营业收入 13.06 亿元；归母净利润 1.41 亿元；扣非归母净利 润 1.34 亿元。 非处方药稳健增长，处方药和健康消费品收入承压。 分业务线来看，2024 年公司非处方药业务稳健增长,处方药业务和健 康消费品业务收入同比下滑。 （1）非处方药：2024 年公司聚焦品牌建设，以大单品引领强品类发 展，非处方药实现营业收入 32.66 亿元，同比增长 7.07%，其中脾胃 品类方面，10 亿级核心大单品健胃消食片收入规模实现双位数增长， 乳酸菌素片和贝飞达两大拳头产品收入规模均突破 6 亿元；咽喉咳 喘品类在核心产品复方鲜竹沥液和复方草珊瑚含片的牵引下，实 ...